Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: results from an updated systematic review and meta-analysis

scientific article

Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: results from an updated systematic review and meta-analysis is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1016/J.EJCA.2013.01.021
P698PubMed publication ID23452992

P2093author name stringJianhong Zhu
Yayuan Zheng
Zhikun Zhou
P2860cites workCancer statistics, 2009Q29547625
P433issue9
P921main subjectsystematic reviewQ1504425
P304page(s)2086-2092
P577publication date2013-02-26
P1433published inEuropean Journal of CancerQ332260
P1476titleOral adjuvant clodronate therapy could improve overall survival in early breast cancer: results from an updated systematic review and meta-analysis
P478volume49

Reverse relations

cites work (P2860)
Q42575269Adjuvant therapy with zoledronic Acid and menopausal status
Q37418209Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis
Q26861586Bisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials
Q33989948Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer
Q46365253Diagnostic PET Imaging of Mammary Microcalcifications Using 64Cu-DOTA-Alendronate in a Rat Model of Breast Cancer

Search more.